Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutaneous Vasculitis Induced by Osimertinib.
Hamada K, Oishi K, Okita T, Chikumoto A, Ohteru Y, Murakawa K, Matsuda K, Uehara S, Suetake R, Yamaji Y, Murata Y, Asami-Noyama M, Edakuni N, Hirano T, Shimomura Y, Matsunaga K. Hamada K, et al. Among authors: murata y. J Thorac Oncol. 2019 Dec;14(12):2188-2189. doi: 10.1016/j.jtho.2019.08.2507. Epub 2019 Sep 24. J Thorac Oncol. 2019. PMID: 31561020 Free article. No abstract available.
A case of cancer-associated myositis with anti-Mi-2 antibody: False-positive anti-transcriptional intermediary factor 1-γ antibody by commercial enzyme-linked immunosorbent assay.
Nawata T, Kubo M, Oishi K, Murata Y, Oishi M, Okazaki Y, Omoto M, Okazaki Y, Kanda T, Kuwana M, Yano M. Nawata T, et al. Among authors: murata y. Int J Rheum Dis. 2019 Jul;22(7):1335-1339. doi: 10.1111/1756-185X.13449. Epub 2018 Dec 26. Int J Rheum Dis. 2019. PMID: 30588776 No abstract available.
Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study.
Oishi K, Hirano T, Murata Y, Hamada K, Uehara S, Suetake R, Yamaji Y, Asami-Noyama M, Edakuni N, Ohata S, Utsunomiya T, Sakamoto K, Onoda H, Matsumoto T, Matsunaga K, Yano M. Oishi K, et al. Among authors: murata y. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619872890. doi: 10.1177/1753466619872890. Ther Adv Respir Dis. 2019. PMID: 31476961 Free PMC article.
Detection of type2 biomarkers for response in COPD.
Yamaji Y, Oishi K, Hamada K, Ohteru Y, Chikumoto A, Murakawa K, Matsuda K, Suetake R, Murata Y, Ito K, Asami-Noyama M, Edakuni N, Hirano T, Matsunaga K. Yamaji Y, et al. Among authors: murata y. J Breath Res. 2020 Feb 25;14(2):026007. doi: 10.1088/1752-7163/ab71a4. J Breath Res. 2020. PMID: 32000146
Impact of sinus surgery on type 2 airway and systemic inflammation in asthma.
Hamada K, Oishi K, Chikumoto A, Murakawa K, Ohteru Y, Matsuda K, Uehara S, Suetake R, Ohata S, Murata Y, Yamaji Y, Asami-Noyama M, Ito K, Edakuni N, Hirano T, Matsunaga K. Hamada K, et al. Among authors: murata y. J Asthma. 2021 Jun;58(6):750-758. doi: 10.1080/02770903.2020.1729380. Epub 2020 Feb 19. J Asthma. 2021. PMID: 32050820
A Novel Role of Growth Differentiation Factor (GDF)-15 in Overlap with Sedentary Lifestyle and Cognitive Risk in COPD.
Hirano T, Doi K, Matsunaga K, Takahashi S, Donishi T, Suga K, Oishi K, Yasuda K, Mimura Y, Harada M, Suizu S, Murakawa K, Chikumoto A, Ohteru Y, Matsuda K, Uehara S, Hamada K, Ohata S, Murata Y, Yamaji Y, Asami-Noyama M, Edakuni N, Kakugawa T. Hirano T, et al. Among authors: murata y. J Clin Med. 2020 Aug 24;9(9):2737. doi: 10.3390/jcm9092737. J Clin Med. 2020. PMID: 32847145 Free PMC article.
A New Dyspnea Evaluation System Focusing on Patients' Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty.
Oishi K, Matsunaga K, Harada M, Suizu J, Murakawa K, Chikumoto A, Ohteru Y, Matsuda K, Uehara S, Hamada K, Ohata S, Murata Y, Yamaji Y, Asami-Noyama M, Edakuni N, Kakugawa T, Hirano T. Oishi K, et al. Among authors: murata y. J Clin Med. 2020 Nov 6;9(11):3580. doi: 10.3390/jcm9113580. J Clin Med. 2020. PMID: 33172080 Free PMC article.
2,684 results